Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis
In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes
Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees
ACS Asks Higher NCI Authorization
Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer
AACI Says Fund Reductions Hurt Cancer Centers
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?









